[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Compared vaccine adverse effects", "description": "India\n\nhttps://www.mohfw.gov.in\n\nCases, + 216,850\n\nDeaths, + 1,183 = 174,308\n\nVaccinations, 117,223,509\n\nhttps://www.bbc.co.uk/news/av/world-asia-india-56747867\n\nInfection drivers\n\nWorkplaces\n\nMarkets and malls have reopened\n\nTransport operating at full capacity\n\nBig weddings\n\nFestivals\n\nElection rallies\n\nProbable new variants\n\nIsrael\n\nPopulation 9.3 million\n\n\nUS and UK vaccination rates \n\n UK, 48% of overall population\n\nI guess the difference won't bother most news consumers much but I'd like to think your viewers might be more discerning, (Tony)\n\nCerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID -19 cases and a comparison with 489,871 people receiving a COVID -19 mRNA vaccine\n\nCan help contextualize the risks and benefits of vaccination in this regard\n\nhttps://www.ox.ac.uk/news/2021-04-15-risk-rare-blood-clotting-higher-covid-19-vaccines\n\nhttps://osf.io/a9jdq/\n\nUsing an electronic health records network\n\nAbsolute incidence of cerebral venous thrombosis (CVT) in the two weeks following:\n\n(Incidence of portal vein thrombosis, PVT also assessed)\n\nCOVID-19 diagnosis (N=513,284)\n\nInfluenza (N=172,742)\n\nReceipt of the BNT162b2 (Pfizer) or mRNA-1273 (Moderna) COVID-19 vaccines (N=489,871)\n\nThe incidence of CVT after COVID-19 diagnosis\n\nCVT = 39.0 per million people\n\nThe incidence of CVT after influenza diagnosis\n\nCVT = Zero per million people\n\nIncidence of CVT after receiving BNT162b2 or mRNA-1273 vaccine\n\nCVT = 4.1 per million people\n\nThe incidence of PVT after COVID-19 diagnosis\n\nPVT = 436\n\nThe incidence of PVT after influenza diagnosis\n\nPVT = 98\n\nIncidence of PVT after receiving BNT162b2 or mRNA-1273 vaccine\n\nPVT = 44 per million\n\nCVT incidence observed across the entire health records network\n\n0.41 per million people over any 2-week period\n\nLaboratory test results, available in a subset of the COVID-19 patients, suggestive of:\n\nRaised D-dimer, lowered fibrinogen, and an increased rate of thrombocytopenia in the CVT and PVT groups\n\nCVT Mortality = 20% in 2 weeks after CoViD\nPVT mortality = 18.8% in 2 weeks after CoViD\n\nLatest estimate from the European Medicines Agency\n\nIncidence associated with ChAdOx1 nCoV-19 vaccine \n\nCVT = 5.0 per million people\n\nSplanchnic thrombosis by the EMA following vaccination with ChAdOx1\n\n(portal, splenic, mesenteric)\n\n53 cases out of 34 million people\n\n1.6 per million people", "link": "https://www.youtube.com/watch?v=_jFYrpAkQwA", "date_published": "2021-04-16 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Aspirate to vaccinate!", "description": "Do we need to change vaccination protocols?\n\nDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada\n\nhttps://ashpublications.org/blood/article/109/7/2832/125650/Adenovirus-induced-thrombocytopenia-the-role-of\n\nThrombocytopenia has been consistently reported following the administration of adenoviral gene transfer vectors\n\nAdenovirus-induced thrombocytopenia is a potentially serious complication of gene therapy protocols using this type of vector. \n\nUnderstanding its mechanism may help the development of measures to prevent this adverse event. \n\nIn this report, we have studied platelet-adenovirus interactions in vitro and in vivo after intravenous administration of adenovirus to mice. \n\nWe show that adenovirus induces platelet activation and promotes the formation of platelet-leukocyte aggregates both in vitro and in vivo.\n\nThrombocytopenia occurs between 5 and 24 hours following intravenous administration of adenovirus to mice\n\nAdenovirus activates platelets and induces rapid exposure of P-selectin\n\nAdenovirus activates endothelial cells\n\nIncorrect injection technique\n\nhttps://nyheder.tv2.dk/samfund/2021-03-22-ssi-anbefaler-ny-vaccineteknik-efter-sjaeldne-blodpropper\n\nVaccine technique can be a rare cause of clots\n\nhttps://translate.google.com/translate?sl=da&tl=en&u=https://nyheder.tv2.dk/samfund/2021-03-22-ssi-anbefaler-ny-vaccineteknik-efter-sjaeldne-blodpropper\n\nState Serum Institute of Denmark, now recommends injection aspiration before injecting vaccine\n\nThere is suspicion as to whether accidental injection of the vaccine into a blood vessel could play a role\n\nIntravascular administration may lead to a systemic inflammatory reaction leading to blood clots\n\nDanish nursing council\n\nCovid-19 vaccines should be given with aspiration before injection\n\nhttps://sqd34kucpgoufz3qiuiswlotka--dsr-dk.translate.goog/politik-og-nyheder/nyhed/covid-19-vacciner-skal-gives-med-aspiration-foer-injektion\n\nAspiration is recommended for all approved covid-19 vaccines\n\nConsistent with the Danish Health and Medicines Authority's guidelines\n\nVaccination personnel should ensure that they are injected correctly into a muscle and not into the bloodstream\n\nPossible connection between the AstraZeneca vaccine and rare but serious side effects with blood clots and bleeding\n\nAnd the link to the updated instructions from the Danish Serum Institute\n\nhttps://www.ssi.dk/vaccinationer/injektionsteknik/intramuskulaer-injektion-beorn-og-voksne\n\nGoogle Translate:\n\nhttps://translate.google.com/translate?sl=da&tl=en&u=https://www.ssi.dk/vaccinationer/injektionsteknik/intramuskulaer-injektion-beorn-og-voksne\n\nDanish Nurse association\n\nhttps://dsr.dk/politik-og-nyheder/nyhed/covid-19-vacciner-skal-gives-med-aspiration-foer-injektion\n\nGoogle Translate:\n\nhttps://translate.google.com/translate?sl=da&tl=en&u=https://dsr.dk/politik-og-nyheder/nyhed/covid-19-vacciner-skal-gives-med-aspiration-foer-injektion\n\nhttps://sundhedspolitisktidsskrift.dk/nyheder/4614-myndighed-sadler-om-aendrer-anbefaling-om-vaccineteknik-efter-meldinger-om-farlige-bivirkninger.html\n\nhttps://translate.google.com/translate?hl=&sl=da&tl=en&u=https%3A%2F%2Fsundhedspolitisktidsskrift.dk%2Fnyheder%2F4614-myndighed-sadler-om-aendrer-anbefaling-om-vaccineteknik-efter-meldinger-om-farlige-bivirkninger.html\n\nWhen vaccinating, it is important to make sure that the vaccine does not go directly into the bloodstream. \n\nUK and WHO guidelines\n\nhttps://www.gov.uk/government/collections/immunisation-against-infectious-disease-the-green-book\n\nhttps://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/147915/Green-Book-Chapter-4.pdf\n\nVaccines should not be given intravenously. \n\nIt is not necessary to aspirate the syringe after the needle is introduced into the muscle (WHO, 2004; Plotkin and Orenstein, 2004). \n\nPlotkin SA and Orenstein WA (eds) (2008) Vaccines, 5th edition. Philadelphia: WB Saunders Company. \n\nWorld Health Organization (2004) Immunization in practice: a guide for health workers. WHO. \n\nhttps://apps.who.int/iris/bitstream/handle/10665/193412/9789241549097_eng.pdf?sequence=1&isAllowed=y\n\nTim Spector\n\nhttps://www.youtube.com/watch?v=pD7V26exJuE\n\nWho are these guys?\n\nVitamin D\n\nhttps://vdmeta.com", "link": "https://www.youtube.com/watch?v=WuyAtvwP2H4", "date_published": "2021-04-15 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]